Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease

Jurij Hanzel^{1

2

3}, Christopher Ma^{2

4}, Niels Vande Casteele^{2

5}, Reena Khanna⁶, Vipul Jairath^{2

6

7}, Brian G Feagan^{8

9

10

11}

Affiliations

¹ Department of Gastroenterology, University Medical Center Ljubljana, Ljubljana, Slovenia.
² Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada.
³ , Hullenbergweg 278-308, 1101 BV, Amsterdam, The Netherlands.
⁴ Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, 6D61 Teaching Research Wellness Building, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada.
⁵ Department of Medicine, University of California San Diego, 9500 Gilman Drive #0956, La Jolla, CA, 92093, USA.
⁶ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada.
⁷ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
⁸ Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada. brian.feagan@alimentiv.com.
⁹ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada. brian.feagan@alimentiv.com.
¹⁰ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.
¹¹ Department of Medicine, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.

Published Erratum

Jurij Hanzel et al. Drugs. 2021 Sep.

. 2021 Sep;81(14):1697.

doi: 10.1007/s40265-021-01596-w.

Jurij Hanzel^{1

2

3}, Christopher Ma^{2

4}, Niels Vande Casteele^{2

5}, Reena Khanna⁶, Vipul Jairath^{2

6

7}, Brian G Feagan^{8

9

10

11}

¹ Department of Gastroenterology, University Medical Center Ljubljana, Ljubljana, Slovenia.
² Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada.
³ , Hullenbergweg 278-308, 1101 BV, Amsterdam, The Netherlands.
⁴ Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, 6D61 Teaching Research Wellness Building, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada.
⁵ Department of Medicine, University of California San Diego, 9500 Gilman Drive #0956, La Jolla, CA, 92093, USA.
⁶ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada.
⁷ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.
⁸ Alimentiv, #200, 100 Dundas Street, London, N6A 5B6, ON, Canada. brian.feagan@alimentiv.com.
⁹ Division of Gastroenterology, University of Western Ontario, 1151 Richmond Street, London, N6A 2K7, ON, Canada. brian.feagan@alimentiv.com.
¹⁰ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.
¹¹ Department of Medicine, University of Western Ontario, London, ON, Canada. brian.feagan@alimentiv.com.

No abstract available

Erratum for

Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Hanzel J, et al. Drugs. 2021 Feb;81(3):333-347. doi: 10.1007/s40265-020-01460-3. Drugs. 2021. PMID: 33400241 Review.